And patients with good levels of vitamin D are less likely to die from it.
Patients with good levels of vitamin D are less likely to catch coronavirus – and are less likely to die from it.
Two new studies have researched the impact of the vitamin on the disease, with interesting results.
Dr Michael Holick, a vitamin D expert from the US, recently published a study which found good vitamin D levels can reduce the risk of catching Covid-19 by 54%.
And he found in patients older than 40, those who had sufficient levels of vitamin D were more than 51% less likely to die than patients who were deficient.
‘There is great concern that the combination of an influenza infection and a coronal viral infection could substantially increase hospitalisations and death due to complications from these viral infections,’ Dr Holick said.
Visit our live blog for the latest updates: Coronavirus news live
‘Because vitamin D deficiency and insufficiency is so widespread in children and adults in the US and worldwide, especially in the winter months, it is prudent for everyone to take a vitamin D supplement to reduce risk of being infected and having complications from Covid-19.’
He added the vitamin can also help against other viruses affecting the upper respiratory tract.
Boston University’s school of medicine also found sufficiency of the vitamin is linked with a significantly decreased level of inflammatory markets, and higher blood levels of immune cells.
The higher levels of lymphocytes were tied to the reduction in cytokine storms – the release of too many proteins into the blood too quickly – which is one of the ways the coronavirus infections can kill.
The study, published in the PLOS ONE journal, analysed blood samples from 235 patients admitted to hospital with Covid-19.
These patients were then analysed for the severity of their infections, whether they lost consciousness, if they had difficulty breathing, or if they died.
Get in touch with our news team by emailing us at webnews@metro.co.uk.
For more stories like this, check our news page.
